Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
European Journal of Pharmacology|August 8, 2021
Abaloparatide: A review of preclinical and clinical studiesMikkel Bo BrentBone|November 15, 2021
A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone lossMikkel Bo BrentPharmacology & Therapeutics|March 18, 2023
Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategiesMikkel Bo BrentCalcified Tissue International|October 30, 2022
Contemporary Advances in Computer-Assisted Bone Histomorphometry and Identification of Bone Cells in CultureMikkel Bo Brent, Thomas EmmanuelSports (Basel, Switzerland)|January 22, 2024
Sports Participation and Osteoarthritis in Females: A Systematic ReviewMagnus Brent, Mikkel Bo BrentBone Reports|July 3, 2018
The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy miceMikkel Bo Brent, Jesper Skovhus Thomsen, Annemarie BrüelSystematic Reviews|August 18, 2020
Animal models of disuse-induced bone loss: study protocol for a systematic reviewMikkel Bo Brent, Annemarie Brüel, Jesper Skovhus ThomsenFrontiers in Endocrinology|November 9, 2020
The Efficacy of PTH and Abaloparatide to Counteract Immobilization-Induced Osteopenia Is in General SimilarMikkel Bo Brent, Jesper Skovhus Thomsen, Annemarie BrüelScientific Reports|June 11, 2021
Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in miceMikkel Bo Brent, Jesper Skovhus Thomsen, Annemarie BrüelBone|April 10, 2022
Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female ratsMikkel Bo Brent, Annemarie Brüel, Jesper Skovhus ThomsenPageof 3